Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study by Kuemmel, Sherko, Tondini, Carlo A., Abraham, Jacinta, Nowecki, Zbigniew, Itrych, Bartosz, Hitre, Erika, Karaszewska, Bogusława, Juárez-Ramiro, Alejandro, Morales-Vásquez, Flavia, Pérez-García, Jose Manuel, Cardona-Huerta, Servando, Monturus, Estefania, Sequi, Marco, Restuccia, Eleonora, Benyunes, Mark, Martín, Miguel

Get full text

PO-070: Experience of induction chemotherapy in head and neck tumors ECIVb in Mexico City by Villavicencio-Queijeiro, M, Aura Erazo Valle-Solis, A.E.V.S, Alejandro Juarez Ramiro, A.J.R, Hector Gurrola Machuca, H.G.M, Josue Perez Mora, J.P.M

Get full text

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study by Cohen, Ezra E W, Soulières, Denis, Le Tourneau, Christophe, Dinis, José, Licitra, Lisa, Ahn, Myung-Ju, Soria, Ainara, Mach, Nicolas, Mehra, Ranee, Burtness, Barbara, Zhang, Pingye, Cheng, Jonathan, Swaby, Ramona F, Acosta-Rivera, Mirelis, Adkins, Douglas R., Aghmesheh, Morteza, Ahn, Myung-Ju, Airoldi, Mario, Aleknavicius, Eduardas, Al-Farhat, Yousuf, Algazi, Alain P., Almokadem, Salah, Alyasova, Anna, Bauman, Jessica R., Benasso, Marco, Berrocal, Alfonso, Bray, Victoria, Burtness, Barbara Ann, Caponigro, Francesco, Castro, Ana, Cescon, Terrence P., Chan, Kelvin, Chaudhry, Arvind, Chauffert, Bruno, Cohen, Ezra, De Boer, J.P., Dietz, Andreas, Dinis, Jose, Dupuis, Charlotte, Digue, Laurence, Escobar Alvarez, Yolanda, Evans, Mererid, Fidler, Mary Jo, Forster, Martin David, Friesland, Signe, Ganti, Apar K., Geoffrois, Lionnel, Grant, Cliona, Gruenwald, Viktor, Harrington, Kevin, Horvai, Geza, Inciura, Arturas, Jang, Raymond, Jankowska, Petra, Jimeno, Antonio, Joseph, Mano, Juarez Ramiro, Alejandro, Karaszewska, Boguslawa, Kawecki, Andrzej, Keilholz, Ulrich, Keller, Ulrich, Kocsis, Judit, Kotecki, Nuria, Kozloff, Mark F., Lambea, Julio, Landherr, Laszlo, Lantsukhay, Yuri, Lazarev, Sergey Alexandrovich, Lee, Lip Way, Le Tourneau, Christophe, Licitra, Lisa, Martincic, Danko, Matorin, Oleg Vladmirovhich, McGrath, Margaret, Machiels, Jean-Pascal, Mehra, Ranee, Misiukiewicz, Krzysztof, Morris, John C., Mufazalov, Fagim Fanisovich, Niu, Jiaxin, Pamoorthy Srinivasan, Devraj, Perez Segura, Pedro, Rauch, Daniel, Ribeiro, Maria Leonor, Rodriguez, Cristina, Rolland, Frederic, Russo, Antonio, Ruzsa, Agnes, Sanches, Frederico, Shin, Sang-Won, Shtiveland, Mikhail, Soulieres, Denis, Specenier, Pol, van Herpen, Carla M.L., Velez-Cortes, Hector A., Walsh, William V., Winterhalder, Ralph, Wojtukiewicz, Marek, Wong, Deborah, Zandberg, Dan

Get full text

NTCT-05EFFICACY AND SAFETY ASSESSMENT OF THE USE OF BEVACIZUMAB AND TEMOZOLOMIDE PLUS RADIOTHERAPY IN PATIENTS WITH RECENTLY DIAGNOSED GLIOBLASTOMA, A SINGLE INSTITUTION EXPERIENCE by Murillo-Medina, Karina, Guerrero-Maldonado, Amancio, Garcia-Navarro, Victor, Juarez-Ramiro, Alejandro, Erazo-Valle-solis, Aura Argentina, Cervantes-Sanchez, Guadalupe

Get full text

ATNT-29TREATMENT OF GLIOBLASTOMA: USE OF BEVACIZUMAB AFTER FIRST PROGRESSION. EXPERIENCE OF 20 DE NOVIEMBRE ISSSTE MEDICAL CENTER, MEXICO CITY by Pérez, Josué Mora, Ramiro, Alejandro Juárez, Solls, Aura Erazo Argentina Valle

Get full text